[miR-29a-3p Targets Hepatoma-Derived Growth Factor to Inhibit the Proliferation and Promote the Apoptosis of E6-1

Jian Zhou1, Chun-Lan Huang2, Heng-Wei Liu1

  • 1Department of Hematology, The Third People's Hospital of Chengdu, Chengdu 610031, Sichuan Province, China.

Abstract

Insights

MicroRNA-29a-3p (miR-29a-3p) inhibits acute lymphoblastic leukemia (ALL) cell proliferation and promotes apoptosis by targeting hepatoma-derived growth factor (HDGF). Upregulating miR-29a-3p offers a potential therapeutic strategy for ALL.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Context:

  • Acute lymphoblastic leukemia (ALL) is a hematological malignancy with complex regulatory mechanisms.
  • Hepatoma-derived growth factor (HDGF) has been implicated in various cancers, including leukemia.
  • MicroRNAs (miRNAs) play crucial roles in post-transcriptional gene regulation and are often dysregulated in cancer.

Purpose:

  • To investigate the regulatory role of miR-29a-3p in ALL.
  • To determine the relationship between miR-29a-3p and HDGF in ALL cells.
  • To assess the impact of miR-29a-3p on the proliferation and apoptosis of the ALL cell line E6-1.

Summary:

  • HDGF expression was elevated, while miR-29a-3p was downregulated in ALL patients and cell lines compared to healthy controls.
  • Overexpression of miR-29a-3p in E6-1 cells led to decreased proliferation and increased apoptosis, evidenced by changes in CyclinD1, Bcl-2, p21, and Bax.
  • Dual luciferase reporter assays confirmed that miR-29a-3p directly targets HDGF. Overexpression of HDGF counteracted the effects of miR-29a-3p.

Impact:

  • This study elucidates a novel regulatory pathway involving miR-29a-3p and HDGF in ALL.
  • Findings suggest that miR-29a-3p acts as a tumor suppressor in ALL by inhibiting cell proliferation and inducing apoptosis.
  • miR-29a-3p represents a potential therapeutic target for ALL treatment.